Skip to main content

Table 1 Geographical pattern of immune checkpoint inhibitor-related haemophagocytic lymphohistiocytosis reporting rate

From: Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports

Country of primary source Total number of
ICI-related safety reports
Number of ICI-related HLH safety reports ICI-related HLH reporting rate (%)
France 3526 14 0.4
Japan 6421 11 0.2
Germany 1901 3 0.2
Switzerland 830 1 0.1
Canada 1279 1 0.08
US of America 24'998 8 0.03
  1. Abbreviations: ICI immune checkpoint inhibitor, HLH haemophagocytic lymphohistiocytosis